A PHARMACEUTICAL COMPOSITION COMPRISING PEG-IFN-α2A

摘要

This invention relates to a pharmaceutical composition for the treatment of chronic hepatitis c infection comprising peg-ifn-α2A conjugates having the formula where R and R' are methyl, X is NH, and n and n' are individually or both either 420 or 520 and Ribavirin.